Literature DB >> 7973120

Retinal toxicity of high dose intravitreal ganciclovir.

B R Saran1, A M Maguire.   

Abstract

BACKGROUND: Intravitreal administration of ganciclovir has been used to treat cytomegalovirus (CMV) retinitis in patients with acquired immune deficiency syndrome (AIDS) who are unable to tolerate systemic antiviral therapy. Although retinal toxicity from intravitreal ganciclovir has been observed in animal experiments, to our knowledge, retinal toxicity from intravitreal ganciclovir has not been reported in humans.
METHODS: A case of inadvertent intravitreous injection of a high dose of ganciclovir (40 mg/0.1 ml) for CMV retinitis in a patient with AIDS is presented.
RESULTS: Despite immediate intervention with vitreous surgery, permanent retinal damage and visual loss developed. Clinical observations and photographic documentation are provided.
CONCLUSION: Retinal toxicity can occur from a high-dose intravitreal ganciclovir injection. This toxicity may result from the high alkaline nature of this preparation, from osmotic damage, or from a direct effect of the concentrated ganciclovir.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7973120     DOI: 10.1097/00006982-199414030-00010

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  A case of CMV endotheliitis treated with intravitreal ganciclovir injection.

Authors:  Won Seok Choi; Joon Hee Cho; Ha Kyoung Kim; Hyun Soo Kim; Young Joo Shin
Journal:  Korean J Ophthalmol       Date:  2013-02-27

2.  Repeated intraocular crystallization of ganciclovir in one eye after bilateral intravitreal injections: a case report.

Authors:  Lawrence P L Iu; Michelle C Y Fan; Wai-Ching Lam; Ian Y H Wong
Journal:  BMC Ophthalmol       Date:  2018-02-09       Impact factor: 2.209

3.  Extralesional microvascular and structural macular abnormalities in cytomegalovirus retinitis.

Authors:  Nida Wongchaisuwat; Sansanee Khongpipatchaisiri; Sutasinee Boonsopon; Pitipol Choopong; Nattaporn Tesavibul; Supalert Prakhunhungsit; Somanus Thoongsuwan; Nuttawut Rodanant; Nopasak Phasukkijwatana
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

Review 4.  Management of cytomegalovirus corneal endotheliitis.

Authors:  Angela H Y Wong; Wee Nie Kua; Alvin L Young; Kelvin H Wan
Journal:  Eye Vis (Lond)       Date:  2021-01-14

5.  Does ganciclovir exert retinal toxicity after multiple continuous intravitreal injections?

Authors:  Feng Hu; Ya Ma; Xiaoyan Peng
Journal:  BMC Infect Dis       Date:  2021-07-12       Impact factor: 3.090

6.  Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis.

Authors:  Pitipol Choopong; Kamolporn Vivittaworn; Duanphen Konlakij; Somanus Thoongsuwan; Auengporn Pituksung; Nattaporn Tesavibul
Journal:  BMC Infect Dis       Date:  2016-04-18       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.